Amneal Pharmaceuticals Inc (AMRX) stock is lower by -44.49% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives AMRX stock a score of 31 out of a possible 100.
That rank is influenced by a long-term technical score of 8. AMRX's rank also includes a short-term technical score of 15.
AMRX has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on AMRX!
Amneal Pharmaceuticals Inc (AMRX) stock is up 7.78% while the S&P 500 has risen 0.38% as of 3:22 PM on Thursday, Aug 18. AMRX has risen $0.20 from the previous closing price of $2.57 on volume of 1,220,766 shares. Over the past year the S&P 500 has fallen -2.50% while AMRX is lower by -44.49%. AMRX lost -$0.89 per share in the over the last 12 months.
Click Here to get the full Stock Report for Amneal Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
